Terumo has yet to establish a direct causal relationship between the deaths and the delivery system separation issues.

The Opuswave system combines the deep vessel visualisation of IVUS with the high-resolution surface imaging of OFDI.

Terumo announced today that it initiated a voluntary recall of specific models of its Relay Pro thoracic stent graft system.

Addresses the need to balance the deep vessel visualization of IVUS with the high-resolution surface detail of OFDI SOMERSET, N.J., June 29, 2026 /PRNewswire/ -- Terumo Interventional Systems (TIS), a ...

Today, the US Food and Drug Administration announced a recall of the Solopath balloon expandable transfemoral system and the Solopath recollapsible balloon access system, both made by Terumo Medical ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Terumo Cardiovascular's CDI OneView Monitoring System, which aims to enhance patient monitoring during surgery. The system is ...

TOKYO, Sept. 17, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical technology, today celebrates its 100 th anniversary. The company, based in Tokyo, boasts over 25,000 ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Terumo (TSE:4543) is back in ...

Terumo Corp. detailed financials by Barron's. View 4543 business summary and company performance, for a clear financial breakdown.

In 2018, top leaders at Terumo Medical Corporation, a leading manufacturer of medical devices and supplies, needed solutions to streamline and simplify their growing business. After steadily building ...